Advertisement
Screener

Allarity Therapeutics, Inc. (ALLR) Conversion of Stock, Shares Issued

0.8 / 5 stars · 3/18 Roast Me

Allarity Therapeutics, Inc. Conversion of Stock, Shares Issued

Allarity Therapeutics, Inc. (ALLR) reported Conversion of Stock, Shares Issued of 3.63 million shares for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-05.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:ConversionOfStockSharesIssued1 · last filed 2024-08-05

  • Allarity Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2023-06-30 was 223.86K shares, a 49.24% decline year-over-year.
  • Allarity Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2022-09-30 was 976.86K shares.
  • Allarity Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2022-06-30 was 441.00K shares.
Period endConversion of Stock, Shares IssuedConversion of Stock, Shares Issued 3 monthConversion of Stock, Shares Issued 6 monthConversion of Stock, Shares Issued 9 month
2024-06-303.63M shares
10-Q · filed 2024-08-05
2024-01-141.42K shares
10-Q · filed 2024-05-14
2023-06-30223.86K shares
10-Q · filed 2023-08-14
3.63M shares
10-Q · filed 2024-08-05
2022-09-30976.86K shares
10-Q · filed 2022-11-14
1.42M shares
derived: sum of 2 quarters · filed 2022-11-14
2.16M shares
10-Q · filed 2022-11-14
2022-06-30441.00K shares
10-Q · filed 2022-10-07
1.19M shares
10-Q · filed 2022-10-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Lipocine Inc. (LPCN)United States$0.017B-1.79
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B